Twenty lines of patient-derived xenografts (PDXs) of relapsed high-PD-L1(+) GATA3/CR5/6-negative NMIBC were developed, of which 10 lines represented high-grade tumors and the other ones, low-grade bladder cancer. The gene discussed is GATA3; the disease is urinary bladder cancer.